p95HER2 Methionine 611 Carboxy-Terminal fragment is predictive of Trastuzumab adjuvant treatment benefit in the FinHer trial Skip to main content Scroll Back to Top Close Menu
Individuals & Patients Providers Health Systems & Organizations Biopharma & Investigators
Manuscript
p95HER2 Methionine 611 Carboxy-Terminal fragment is predictive of Trastuzumab adjuvant treatment benefit in the FinHer trial March 1, 2018
Saranya Chumsri Jeff Sperinde Heshan Liu Joseph Gligorov Jean-Philippe Spano Martine Antoine Alvaro Moreno Aspitia Winston Tan John Winslow Christos J. Petropoulos Ahmed Chenna Michael Bates Jodi Marie Weidler Weidong Huang Amylou Dueck and Edith A. Perez